Richmond, California
United States
10
2024-02-29
9
2024-10-29
These are the the leading inventors for applications assigned to BioAge Labs, Inc.:
BioAge Labs, Inc. based in Richmond, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
N-oxide inhibitors of NLRP3 inflammasome
#2 | 2024-02-29 ✅ Patent 12,215,087 granted on 2025-02-04Inhibitors of NLRP3 inflammasome
#3 | 2024-02-15 ✅ Patent 12,435,043 granted on 2025-10-07INHIBITORS OF NLRP3 INFLAMMASOME
#4 | 2024-01-23 ✅ Patent 11,881,311 granted on 2024-01-23Survival prediction using metabolomic profiles
#5 | 2023-08-03 ✅ Patent 11,787,805 granted on 2023-10-17N-oxide inhibitors of NLRP3 inflammasome
#6 | 2023-07-06RAGE Fusion Proteins with Improved Stability and Ligand Binding Affinity and Uses Thereof
#7 | 2023-02-16 ✅ Patent 11,708,334 granted on 2023-07-25Inhibitors of NLRP3 inflammasome
#8 | 2022-10-13 ✅ Patent 11,702,391 granted on 2023-07-18Inhibitors of NLRP3 inflammasome
#9 | 2022-04-21 ✅ Patent 11,535,661 granted on 2022-12-27RAGE fusion proteins with improved stability and ligand binding affinity and uses thereof
#10 | 2020-04-16 ✅ Patent 10,913,784 granted on 2021-02-09RAGE fusion proteins with improved stability and ligand binding affinity and uses thereof
Also check out BioAge Labs, Inc.'s (Richmond, United States) applicant profile with 17 patent applications submitted.
339094 ⎘